Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs: a cluster randomised controlled trial

  • Doyle, Joseph (Primary Chief Investigator (PCI))
  • Hellard, Margaret E. (Chief Investigator (CI))
  • Pedrana, Alisa (Chief Investigator (CI))
  • Thompson, Alexander James (Chief Investigator (CI))
  • Stoove, Mark (Chief Investigator (CI))
  • Snelling, Thomas Laurence (Chief Investigator (CI))
  • Scott, Nick (Chief Investigator (CI))
  • Spelman, Tim D. (Chief Investigator (CI))
  • Anderson, David Andrew (Chief Investigator (CI))

Project: Research

Project Details

Project Description

The QuickStart Study will establish and evaluate the integration of hepatitis C testing and treatment into drug and alcohol clinics. We aim to evaluate the effect of rapid testing on treatment uptake and reduction the burden of hepatitis C in the community. We hypothesise that with increased testing, rapid testing will lead to increased treatment uptake and cure, which will have long term public health benefits.
StatusFinished
Effective start/end date1/01/20 → 31/12/23

Keywords

  • hepatitis C infection
  • treatment
  • diagnostic algorithms
  • implementation
  • injecting drug use